De Smidt, 2001 - Google Patents
Cloning and characterization of the capsule transport gene region from Haemophilus paragallinarumDe Smidt, 2001
View PDF- Document ID
- 16837476558494290795
- Author
- De Smidt O
- Publication year
External Links
Snippet
Haemophilus paragallinarum causes an acute respiratory disease of chickens known as infectious coryza (IC), a disease first recognized as a distinct entity in the late 1920's. Since the disease proved to be infectious and primarily affected nasal passages, the name" …
- 239000002775 capsule 0 title abstract description 231
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
- C12R1/46—Streptococcus; Enterococcus; Lactococcus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7125548B2 (en) | Streptococcus suis vaccines and diagnostic tests | |
| Darfeuille-Michaud et al. | R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections | |
| Bhasin et al. | Identification of a gene essential for O‐acetylation of the Staphylococcus aureus type 5 capsular polysaccharide | |
| Guidolin et al. | Genetics of Vibrio cholerae and its bacteriophages | |
| Ogunniyi et al. | Role of SefA subunit protein of SEF14 fimbriae in the pathogenesis of Salmonella enterica serovar Enteritidis | |
| CN1798574B (en) | Acapsular p. multocida hyae deletion mutants | |
| JP3388171B2 (en) | Production of gonococcal PI protein and vaccine | |
| Tatum et al. | Sialic acid uptake is necessary for virulence of Pasteurella multocida in turkeys | |
| KR20000049090A (en) | Helicobacter pylori live vaccine | |
| MXPA02010407A (en) | Isolation and characterization of the csa operon (etec cs4 pili) and methods of using same. | |
| RU2140981C1 (en) | Avirulent strain vibrio cholerae of non 01-serogroup (variants), method of strain preparing (variants), vaccine | |
| De Smidt | Cloning and characterization of the capsule transport gene region from Haemophilus paragallinarum | |
| Thorns et al. | Fimbriae of Salmonella. | |
| EP1181371B1 (en) | Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use | |
| JP7671772B2 (en) | Vaccine containing glycosylated bacteria | |
| Lee et al. | Capsular polysaccharides of Staphylococcus aureus | |
| Sun | Cloning and characterization of lipooligosaccharide (LOS) biosynthetic genes of Haemophilus ducreyi | |
| Jablonski | Development of a cloning system for gene expression in Pasteurella multocida | |
| Pearce | Cloning and analysis of the Escherichia coli K10 and K54 capsule gene clusters | |
| Xu | Identification of antigen-encoding genes of Enterococcus faecalis during human infections and characterization of a gene cluster for the biosynthesis of an antigenic polysaccharide | |
| Mills et al. | Department of Medical Biochemistry | |
| Maley | Genetic studies on Porphyromonas gingivalis W83 | |
| Zhang | Characterization of a new site-specific recombinase and a new Type IV-like pilin operon encoded in the major" pathogenicity island" of Salmonella typhi | |
| Van Zyl | Charactt [sic] erization of a plasmid conferring NAD independence in Haemophilus paragallinarum |